Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.

Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check16 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check24 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check45 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the study's purpose, inclusion and exclusion criteria, and details about the clinical trial. The only notable addition is the mention of 'PD1 plus DC-CIK' and a revision update.SummaryDifference31%
Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.